会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • “HYDROGELS,HYDROGELS,包括这些交叉连接器及其应用的新交叉连接器”
    • WO2014048564A8
    • 2014-05-30
    • PCT/EP2013002876
    • 2013-09-25
    • MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V
    • BÖHM HEIKEHAGEL VALENTINMUNDINGER TABEANUSS ISABELLWEGNER SERAPHINE VALESKALASCHAT SABINEMATEESCU MARKUS MANFRED
    • C07D213/80A61K31/4425A61P43/00C07D213/82C08B37/08
    • C08J3/24C07D213/80C07D213/82C08B37/0072C08J3/075C08J2305/08C08L5/08C08L1/02C08L5/02C08L5/04C08L53/00C08L67/04C08L71/02
    • The present invention relates to novel cross-linkers for hydrogels, in particular for hyaluronan hydrogels, corresponding hydrogels including said cross-linkers and various applications thereof. The cross linker of the invention is a bi- or multifunctional cross-linker comprising or consisting of an aromatic or heteroaromatic ring system with 3-6 C atoms which is coupled via functional groups on at least 2 ring positions with at least 2 terminal groups capable to form a covalent bond with thiol or amino groups, in particular with thiol groups in a thiol-en reaction. The cross-linker may be charged or uncharged. In a specific embodiment, the terminal groups are coupled to carboxy groups of the aromatic or heteroaromatic ring system via an ester or amide bond. More specifically, the cross-linker of the invention is a derivative of pyridine-3, 5-dicarboxylic acid or a corresponding pyridinium salt thereof wherein 2 terminal groups are coupled to the carboxy groups of the pyridine or pyridinium core via an ester or amide bond. In a preferred embodiment, the cross-linker is N3,N5-bis(2-acrylamidoethyl) pyridine-3, 5-dicarboxamide or a 3,5-bis((2-acrylamidoethyl) carbamoyl) -1-methylpyridin-l-ium-halogenide.
    • 本发明涉及用于水凝胶,特别是透明质酸水凝胶的新型交联剂,包括所述交联剂的相应水凝胶及其各种应用。 本发明的交联剂是包含或由具有3-6个C原子的芳族或杂芳族环系统组成的双官能或多功能交联剂,其通过官能团在至少2个环位置与至少2个具有端基的基团 与硫醇或氨基形成共价键,特别是在硫醇-en反应中与硫醇基形成共价键。 交联剂可以带电或不带电。 在具体实施方案中,末端基团通过酯或酰胺键与芳族或杂芳族环系的羧基偶联。 更具体地,本发明的交联剂是吡啶-3,5-二羧酸或其相应的吡啶鎓盐的衍生物,其中2个末端基通过酯或酰胺键与吡啶或吡啶鎓核心的羧基偶联 。 在优选的实施方案中,交联剂是N 3,N 5 - 双(2-丙烯酰胺基乙基)吡啶-3,5-二甲酰胺或3,5-双((2-丙烯酰胺基乙基)氨基甲酰基)-1-甲基吡啶-1- -halogenide。